Of 895 patients with a known pathogenic variant in BRCA1/2 and PALB2 or other breast cancer susceptibility genes, we identified 312 affected female BRCA1/2 and PALB2-positive patients with breast cancer. This evidence concerns the gene BRCA1 and breast carcinoma.